Tennessee Senate Bill 1314

---

Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on January 31 2023 - 25% progression, died in committee
Action: 2023-02-06 - Passed on Second Consideration, refer to Senate Commerce and Labor Committee
Pending: Senate Commerce and Labor Committee
Text: Latest bill text (Draft #1) [PDF]

As introduced, prohibits a healthcare prescriber from issuing a prescription for a dual-purpose prescription medication for diabetes to a person in this state if the person does not have a diagnosis of diabetes; defines a dual-purpose prescription medication for diabetes as a prescription drug that has a listed indication for diabetes and may also be used for purposes of weight loss in persons who do not have a diagnosis of diabetes. - Amends TCA Title 53; Title 56; Title 63; Title 68 and Title 71.

AN ACT to amend Tennessee Code Annotated, Title 53; Title 56; Title 63; Title 68 and Title 71, relative to medications intended for persons with diabetes.

Sen. Paul Bailey [R]

Date	Chamber	Action
2023-02-06	Senate	Passed on Second Consideration, refer to Senate Commerce and Labor Committee
2023-02-02	Senate	Introduced, Passed on First Consideration
2023-01-31	Senate	Filed for introduction

HB1419 (Crossfiled) 2023-02-07 - Assigned to s/c Health Subcommittee

Type	Source
Summary	https://wapp.capitol.tn.gov/apps/Billinfo/default.aspx?BillNumber=SB1314&ga=113
Text	https://www.capitol.tn.gov/Bills/113/Bill/SB1314.pdf
Supplement	https://www.capitol.tn.gov/Bills/113/Fiscal/HB1419.pdf